GILD : Summary for Gilead Sciences, Inc. - Yahoo Finance

U.S. Markets close in 2 hrs 44 mins

Gilead Sciences Inc. (GILD)


NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
72.92+0.08 (+0.11%)
As of 1:16 PM EST. Market open.
People also watch:
CELGBIIBAMGNREGNBMY
Interactive chart
  • 1d
  • 5d
  • 1m
  • 6m
  • YTD
  • 1y
  • 2y
  • 5y
  • 10y
  • Max
1d
Previous Close72.84
Open73.04
Bid72.94 x 500
Ask72.95 x 300
Day's Range72.56 - 73.59
52 Week Range71.39 - 104.79
Volume4,716,750
Avg. Volume9,597,330
Market Cap96.07B
Beta0.93
PE Ratio (TTM)6.74
EPS (TTM)N/A
Earnings DateN/A
Dividend & Yield1.88 (2.55%)
Ex-Dividend DateN/A
1y Target EstN/A
Trade prices are not sourced from all markets
  • Barrons.com2 hours ago

    Gilead Sciences: Forget About Hepatitis C…Everyone Else Is

    After hosting a dinner with Gilead Sciences (GILD), Piper Jaffray's Joshua Schimmer and team contend that investor attention is finally beginning to turn away from hepatitis C. They explain: We hosted ...

  • Reuters3 hours ago

    EU health regulator warns some hep C drugs could reactivate hep B

    The European Medicines Agency warned on Friday that some of the most successful hepatitis C treatments on the market could reactivate hepatitis B in patients, the second time this year it has raised safety concerns over these treatments. The Pharmacovigilance Risk Assessment Committee (PRAC), part of the EMA, said it suspected the reactivation of the hepatitis B virus was due to the rapid reduction of the hepatitis C virus, which is known to suppress the hepatitis B virus.

  • Market Realist5 hours ago

    What Do Analysts Recommend for Gilead Sciences Stock?

    According to a Reuters consensus of 26 brokerage firms on November 22, 2016, 88% of the analysts recommended Gilead as a “buy.”